Lipitor Legal News Articles & Interviews

Bangor, ME Among the ongoing concerns over the statin Lipitor are the potential for type 2 diabetes and cognitive issues such as memory and concentration. Atorvastatin (Lipitor) type 2 diabetes remains one of the biggest frustrations alleged in lawsuits consolidated in the Lipitor Diabetes Lawsuits MDL. Various plaintiffs have alleged that for them, type 2 diabetes appeared to come out of nowhere with no corresponding family history or risk factors for diabetes.

Washington, DC The number of cases in the Lipitor Diabetes Lawsuits MDL has climbed to more than 2,200 and with little wonder: plaintiffs maintain that prior to a label change mandated by the US Food and Drug Administration (FDA) in 2012, few, if any, had little clue that atorvastatin (Lipitor) could trigger type 2 diabetes.

Melbourne, Australia Pfizer may have lost its motion to dismiss in Lipitor lawsuits in the US, but the drugmaker is celebrating a victory in Australia. An Australian consumer watchdog filed a Lipitor lawsuit against Pfizer, alleging the company engaged in anticompetitive practices linked to its sales of generic Lipitor.

Charleston, SC The manufacturer of Lipitor recently attempted to cast off 10 atorvastatin type 2 diabetes cases in the Lipitor Diabetes Lawsuits MDL on grounds that failure-to-warn claims made by the plaintiffs were preempted by federal regulation.

Charleston, SC The number of consolidated Lipitor lawsuits continues to grow and now sits at more than 1,600, according to court documents. Those lawsuits allege that women were not properly warned about the risk of Lipitor side effects, including a reported increased risk of diabetes.

New York, NY As the number of cases in the Lipitor Diabetes Lawsuits MDL continue to spike, Lipitor manufacturer Pfizer Inc. continues to position itself following the expiration of its patent in November 2011. One of those moves, as evidenced by a Bloomberg report earlier this year, is a hoped-for introduction of an over-the-counter (OTC) version of Lipitor (atorvastatin) at some point in the near future.

Charleston, SC Lipitor multidistrict litigation, alleging patients suffered Lipitor side effects and developed diabetes as a result of taking the medication, continue to move forward with regular status conferences. Three more Lipitor lawsuits have been dismissed due to failure to provide required documentation. Among the required documentation that has not been provided is a Plaintiff Fact Sheet and a response to Pfizer’s motion to dismiss.

Charleston, SC Twenty Lipitor lawsuits involved in Lipitor multidistrict litigation have been dismissed from the court for failure to provide required documentation. The lawsuits alleged that plaintiffs suffered from Lipitor side effects as a result of taking the medication.

Washington, DC It is no secret that Lipitor diabetes lawsuits have been growing exponentially, with more than 200 lawsuits recently added to the Lipitor diabetes lawsuits MDL in South Carolina (In re Lipitor (atorvastatin) Litigation, MDL No. 2502, US District Court, District of South Carolina). According to PRWeb Newswire (9/1/14), the litigation count was at 1,162 at the beginning of the month. Given the rapid rise in cases, it is presumed that number is higher still as of this writing.

Philadelphia, PA By August 15, 2014, court records show that 1,162 Lipitor claims have been filed against Pfizer Inc., the manufacturer of the “best-selling prescription drug of all time.” The Lipitor lawsuits filed by plaintiffs who developed Type 2 diabetes allege that Pfizer failed to adequately warn patients and their doctors about the cholesterol medication’s association with diabetes and other risks associated with Lipitor.